• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于女性不孕症的中药:一项更新的荟萃分析。

Chinese herbal medicine for female infertility: an updated meta-analysis.

作者信息

Ried Karin

机构信息

National Institute of Integrative Medicine, Hawthorn, Melbourne, VIC, Australia.

出版信息

Complement Ther Med. 2015 Feb;23(1):116-28. doi: 10.1016/j.ctim.2014.12.004. Epub 2015 Jan 3.

DOI:10.1016/j.ctim.2014.12.004
PMID:25637159
Abstract

OBJECTIVES

To assess the effect of Traditional Chinese herbal medicine (CHM) in the management of female infertility and on pregnancy rates compared with Western medical (WM) treatment and update previous meta-analyses.

METHODS

We searched the Medline and Cochrane databases until December 2013 for randomized controlled trials and meta-analyses investigating Chinese herbal medicine therapy for female infertility and compared clinical pregnancy rates achieved with CHM versus WM drug treatment.

RESULTS

Forty RCTs involving 4247 women with infertility were included in our systematic review. Meta-analysis suggested a 1.74 higher probability of achieving a pregnancy with CHM therapy than with WM therapy alone (risk ratio 1.74, 95%CI: 1.56-1.94; p<0.0001; odds ratio 3.14; 95%CI: 2.72-3.62; p<0.0001) in women with infertility. Trials included women with PCOS, endometriosis, anovulation, fallopian tube blockage, or unexplained infertility. Mean pregnancy rates in the CHM group were 60% compared with 33% in the WM group.

CONCLUSIONS

Our review suggests that management of female infertility with Chinese herbal medicine can improve pregnancy rates 2-fold within a 3-6 month period compared with Western medical fertility drug therapy. In addition, fertility indicators such as ovulation rates, cervical mucus score, biphasic basal body temperature, and appropriate thickness of the endometrial lining were positively influenced by CHM therapy, indicating an ameliorating physiological effect conducive for a viable pregnancy.

摘要

目的

评估中药在女性不孕症治疗中的效果以及与西医治疗相比的妊娠率,并更新以往的荟萃分析。

方法

我们检索了截至2013年12月的Medline和Cochrane数据库,以查找调查中药治疗女性不孕症的随机对照试验和荟萃分析,并比较中药与西医药物治疗的临床妊娠率。

结果

我们的系统评价纳入了40项涉及4247名不孕女性的随机对照试验。荟萃分析表明,在不孕女性中,中药治疗组的妊娠概率比单纯西医治疗组高1.74倍(风险比1.74,95%置信区间:1.56 - 1.94;p<0.0001;优势比3.14;95%置信区间:2.72 - 3.62;p<0.0001)。试验纳入了患有多囊卵巢综合征、子宫内膜异位症、无排卵、输卵管堵塞或不明原因不孕的女性。中药组的平均妊娠率为60%,而西医组为33%。

结论

我们的综述表明,与西医生育药物治疗相比,中药治疗女性不孕症可在3 - 6个月内将妊娠率提高两倍。此外,排卵率、宫颈黏液评分、双相基础体温和子宫内膜适当厚度等生育指标受中药治疗的积极影响,表明其具有改善生理效应,有利于实现可行妊娠。

相似文献

1
Chinese herbal medicine for female infertility: an updated meta-analysis.用于女性不孕症的中药:一项更新的荟萃分析。
Complement Ther Med. 2015 Feb;23(1):116-28. doi: 10.1016/j.ctim.2014.12.004. Epub 2015 Jan 3.
2
Efficacy of Traditional Chinese Herbal Medicine in the management of female infertility: a systematic review.中药在女性不孕管理中的疗效:系统评价。
Complement Ther Med. 2011 Dec;19(6):319-31. doi: 10.1016/j.ctim.2011.09.003. Epub 2011 Oct 5.
3
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.用于多囊卵巢综合征不孕女性的中草药
Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD007535. doi: 10.1002/14651858.CD007535.pub3.
4
Chinese herbal medicine for infertility with anovulation: a systematic review.中药治疗无排卵性不孕症的系统评价。
J Altern Complement Med. 2012 Dec;18(12):1087-100. doi: 10.1089/acm.2011.0371.
5
Chinese herbal medicine for endometriosis.用于治疗子宫内膜异位症的中药
Cochrane Database Syst Rev. 2012 May 16(5):CD006568. doi: 10.1002/14651858.CD006568.pub3.
6
Chinese herbal medicine for endometriosis.用于治疗子宫内膜异位症的中草药
Cochrane Database Syst Rev. 2009 Jul 8(3):CD006568. doi: 10.1002/14651858.CD006568.pub2.
7
Chinese herbal medicine for treating recurrent urinary tract infections in women.用于治疗女性复发性尿路感染的中草药
Cochrane Database Syst Rev. 2015 Jun 4;2015(6):CD010446. doi: 10.1002/14651858.CD010446.pub2.
8
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.用于多囊卵巢综合征不孕女性的中草药
Cochrane Database Syst Rev. 2010 Sep 8(9):CD007535. doi: 10.1002/14651858.CD007535.pub2.
9
Herbal therapeutics for female infertility: A systematic review and meta-analysis.草药疗法治疗女性不孕:系统评价和荟萃分析。
J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117258. doi: 10.1016/j.jep.2023.117258. Epub 2023 Sep 29.
10
Chinese herbal medicines for unexplained recurrent miscarriage.用于不明原因复发性流产的中草药。
Cochrane Database Syst Rev. 2016 Jan 14;2016(1):CD010568. doi: 10.1002/14651858.CD010568.pub2.

引用本文的文献

1
Effectiveness and Safety of Korean Medicine in Treating Female Infertility: A Prospective Multicenter Observational Study.韩医学治疗女性不孕症的有效性和安全性:一项前瞻性多中心观察性研究。
Int J Womens Health. 2025 Jun 14;17:1771-1787. doi: 10.2147/IJWH.S520044. eCollection 2025.
2
Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management.多囊卵巢综合征(PCOS)的营养与草药干预:对饮食方法、常量营养素影响及管理中使用的草药的全面综述
J Health Popul Nutr. 2025 May 2;44(1):143. doi: 10.1186/s41043-025-00899-y.
3
Cai's prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders.
蔡氏方通过 ARHGAP4 抑制卵巢反应不良患者颗粒细胞凋亡。
J Ovarian Res. 2024 Feb 14;17(1):40. doi: 10.1186/s13048-024-01363-x.
4
Herbal Medicine for Postpartum Pain: A Systematic Review of Puerperal Wind Syndrome (Sanhupung).用于产后疼痛的草药医学:产褥风综合征(三胡蓬)的系统评价
Healthcare (Basel). 2023 Oct 16;11(20):2743. doi: 10.3390/healthcare11202743.
5
Effects of natural products on polycystic ovary syndrome: From traditional medicine to modern drug discovery.天然产物对多囊卵巢综合征的影响:从传统医学到现代药物发现
Heliyon. 2023 Oct 11;9(10):e20889. doi: 10.1016/j.heliyon.2023.e20889. eCollection 2023 Oct.
6
Are epigenetic mechanisms and nutrition effective in male and female infertility?表观遗传机制和营养在男性和女性不孕中是否有效?
J Nutr Sci. 2023 Sep 26;12:e103. doi: 10.1017/jns.2023.62. eCollection 2023.
7
Lam.: a comprehensive review on active components, health benefits and application.拉姆:关于活性成分、健康益处及应用的全面综述。
RSC Adv. 2023 Aug 15;13(35):24353-24384. doi: 10.1039/d3ra03584k. eCollection 2023 Aug 11.
8
The mechanism of in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking.基于网络药理学和分子对接技术分析 改善多囊卵巢综合征的作用机制。
J Pharm Pharm Sci. 2023 Feb 15;26:11234. doi: 10.3389/jpps.2023.11234. eCollection 2023.
9
Impact of Chinese Herbal Medicine on Glucolipid Metabolic Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.中药对多囊卵巢综合征女性糖脂代谢结局的影响:一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2022 Sep 30;2022:3245663. doi: 10.1155/2022/3245663. eCollection 2022.
10
Huayu Jiedu Fang Protects Ovarian Function in Mouse with Endometriosis Iron Overload by Inhibiting Ferroptosis.化瘀解毒方通过抑制铁死亡保护子宫内膜异位症铁过载小鼠的卵巢功能。
Evid Based Complement Alternat Med. 2022 Aug 30;2022:1406820. doi: 10.1155/2022/1406820. eCollection 2022.